Vivaldis

What Vivaldis does

Vivaldis is an innovation-led Indian animal healthcare company focused on companion animal health, developing and distributing a broad formulary of therapeutic medications, nutraceuticals, and specialty veterinary diets for dogs and cats. Founded in 2015 by Kunal Khanna (CEO & co-founder) and headquartered in Pune, the company sells to veterinary professionals and pet parents across India and in over 30 international markets. In 2026, Sun Pharma acquired a 60% controlling stake for approximately Rs 143 crore, establishing Vivaldis as a subsidiary of one of India's largest pharmaceutical groups while retaining operational leadership under the founding team.

The company's product portfolio spans more than 60 SKUs across therapeutic categories including renal care, cardiac health, oncology, neurology, liver health, dermatology, joint care, pain management, parasiticides, immunity, respiratory, and digestive health, alongside a complete veterinary diet line (gastrointestinal, urinary, renal, hypoallergenic, oncology support, weight management, hepatic, and recovery). Vivaldis differentiates through patented formulations — notably Impromune (immunomodulator), Kardioli and Alzer (built on proprietary Molecular Activation Technology), and SUBAvet-IT 50 (SERBA delivery technology for antifungal agents) — and through FDA-approved assets such as Tocerapet (targeted oral chemotherapy for dogs) and Grapitail (EP4 receptor inhibitor). Strategic supply partnerships with Catalysis and Bioiberica bring globally benchmarked formulations into the Indian market.

Vivaldis operates a dual go-to-market motion: a B2B channel that distributes therapeutics, nutraceuticals, and veterinary diets through veterinarians and clinics across India and 30+ countries via channel partners, and a 100% digital D2C sub-brand called Bark Out Loud (launched in 2020) that sells premium pet nutrition, treats, skincare, and supplements directly to pet parents, with explicit focus on Tier-2 and Tier-3 Indian cities alongside metros. Pricing is not publicly disclosed. Customer segments split between veterinary professionals (primary therapeutic channel) and pet parents (Bark Out Loud consumer channel), with companion animals (dogs and cats) as the end beneficiaries across all chronic and acute disease categories addressed.

Name

Vivaldis

Legal name

Vivaldis

Website

https://vivaldis.co.in

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Vivaldis is an India-based animal healthcare company developing and distributing patented therapeutic medications, nutraceuticals, and specialty veterinary diets for companion animals through veterinary professionals and its Bark Out Loud D2C brand.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals & Animal Healthcare

NAICS

Animal Food Manufacturing (31111), Dog and Cat Food Manufacturing (311111)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology) (HLAMAIAH)

akta.pro secondary industries

Species-Specific Supplements (Dog/Cat/Other Companion Species) (HLAMALAN), Immune Support Supplements (HLAMALAE), Animal Health OTC Retail (Parasite Control, Basic Care) (HLAMAIAJ), Functional & Veterinary Diet Pet Food (CRADAFAF), Allergy & Anti-Inflammatory Supplements (HLAMALAL)

Keywords

• Veterinary therapeutics
• Companion animal health
• Veterinary nutraceuticals
• Veterinary prescription diets
• Pet care products

Headquarters

HQ city

Pune

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations

Revenue model

1. Veterinary Pharmaceuticals: Sale of therapeutic medications for pets covering chronic disease management including renal care, cardiac health, oncology, neurology, liver health, pain management, and other therapeutic categories.
2. Veterinary Diets: Specialized therapeutic and maintenance diets for dogs and cats addressing conditions such as gastrointestinal disorders, urinary issues, renal support, weight management, hepatic support, and oncology support.
3. Nutraceuticals: Sale of nutritional supplements including joint care products, digestive health supplements, immunity boosters, and specialty nutrition products for pets.
4. Bark Out Loud Consumer Products: Premium pet care consumer products including food, treats, skincare, and supplements sold directly to pet parents through D2C channels.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Vivaldis develops, brands and distributes a comprehensive portfolio of veterinary therapeutics, nutraceuticals, and specialty therapeutic diets for companion animals (dogs and cats), covering renal care, cardiology, oncology, neurology, dermatology, parasiticide control, pain management, joint care, immunity, and digestive health. Through its Bark Out Loud sub-brand, the company also sells science-backed premium pet nutrition, treats, skincare and supplements directly to pet parents via owned digital channels.

Product overview

Vivaldis is an innovation-led animal health company offering a comprehensive portfolio of veterinary therapeutics, nutraceuticals, and specialty diets for companion animals. The product ecosystem includes therapeutic medications across major health categories (renal, cardiac, oncology, dermatology, neurology, liver, digestive health, pain management, joint care, parasiticides, and antiemetics), supported by a line of EasyPill administration aids. Veterinary diets address chronic conditions including gastrointestinal disorders, urinary issues, renal support, weight management, oncology support, hepatic support, and recovery. Global partnerships with Catalysis and Bioiberica bring advanced formulations to India. The Bark Out Loud sub-brand serves the premium pet care consumer market with science-backed nutrition products.

Differentiator

Problem solved

Functional benefit

Products and services

• Renal Care Therapeutics Range of therapeutics for chronic kidney disease and renal-related conditions in dogs and cats, including CK-Reno & CK-Reno Feline (botanical/nutraceutical kidney support), Phosclear (phosphate binder), Rinonadyl (azotemia management in CKD), Renalof (urolithiasis prophylaxis), Cranbact (UTI with anti-adherence effect), and Reno-nex (nephroprotection with uremic toxin binding and gut-kidney axis modulation).
• Cardiac Health Therapeutics Veterinary cardiac therapeutics including Pimoben and Pimoben Solo (fixed-dose combinations for CHF in myxomatous mitral valve disease and dilated cardiomyopathy), Kardioli (cardio-protector with Molecular Activation Technology), and Omnipulse (cardiovascular nutrient blend with amino acids and antioxidants).
• Cancer Care Therapeutics Oncology portfolio including Ocoxin (supportive care that reduces tumor recurrence and spread) and Tocerapet (FDA-approved first targeted oral chemotherapy for dogs - a tyrosine kinase inhibitor for cancer).
• Dermatology / Skin Care Therapeutics Range covering atopic dermatitis, parasiticides, and topical therapy including Atopivet (collar plus oral suspension for atopic dermatitis), Atosporin (immunomodulator for canine atopic dermatitis), EFA Pet (Omega-3 supplement from Antarctic krill), Oclapet (JAK inhibitor for flea/food/atopic/contact allergies), Terbopet-M Cream (topical antifungal/anti-inflammatory), Viv Keto and Viv Silky Shampoos, Pirofur (anti-pruritus shampoo), VI-FI Forte Spot-On (flea/tick/lice protection), Exsite (ectoparasite wash), Prurigo (cortisone spray), Vetecto (tick/flea/mite chewable and spot-on), SUBAvet-IT 50 (SERBA-technology antifungal), Ceravet (ceramide-restoring skin barrier), and Vinectra Duo Spot-On (endo/ecto-parasiticide including tapeworm).
• Pain & Inflammation Management Therapeutics Pain management including Grapitail (FDA-approved non-COX inhibiting NSAID, EP4 receptor blocker for canine OA), Firotail (first Coxib for companion animals in India), Cartail (canine NSAID with lowest GI side effects), Curcupet (curcumin supplement with 12-hour peak serum), and Robenatail (first USFDA-approved oral NSAID for cats in India).
• Joint & Bone Health Therapeutics Joint care including Condrovet (Chondroitin, Glucosamine, Mobilee HA, native Type II collagen), Folrex (osteoarthritis and rheumatoid arthritis with joint regeneration), and Kalsis (bone mass and fracture-healing support).
• Immunity Therapeutics Patented immunity products including IMPROME (Impromune) - patented immunomodulator acting on innate and adaptive immunity via AHCC and nucleotides - and Viusid / Viusid Detox (oxidative stress reduction, antiviral, hepatic, renal, and systemic detoxification).
• Neurology Therapeutics Neurology products including L-Sametine (neuronal stability, protection, and delayed degeneration, liquid formulation) and Alzer (neuroprotection with Molecular Activation Technology for senility symptoms and cognitive deterioration).
• Liver Health Therapeutics Liver therapeutics including Prolivet (high-concentration SAMe and Silybin for hepatocyte proliferation/protection/anti-inflammation), Unomarin (cellular metabolism optimization with hepatocyte proliferation/anti-fibrotic effects), and Ursopet (hepatobiliary support, bile acid improvement, gallstone reduction).
• Digestive Health Therapeutics Digestive product range including Entero-Chronic (intestinal lining repair), Haltorin (smart-clay diarrhea control), Viusid Detox, SynFosium (soil-based probiotic, high temperature/pH resilience), Enterosecure BD (enzyme/probiotic combo for bloating and gas), Carminal (GERD/esophagitis, peptic ulcer relief), and Probioplus (heat-stable comprehensive gut recovery formula).
• Antiemetic Therapeutics Anti-emetics including Emepet (spray-form antiemetic with direct oral-cavity absorption avoiding first-pass hepatic metabolism) and Vet Maro (antiemetic for chemotherapy, motion sickness, and disease-induced emesis).
• Respiratory Therapeutics ASBRIP - respiratory tract infection treatment with antibacterial, antiviral, antispasmodic, antioxidant and soothing properties.
• Ear Care Therapeutics Ear-care including Clearify (TRIS-EDTA ear cleanser with alkalinizing and antibiotic-potentiating action) and Otisoothe (otitis management with antibacterial and antifungal control plus soothing effect).
• Wound Management Therapeutics Wound-care products including Relaxzyme (proprietary systemic enzyme blend for anti-inflammatory wound healing and fibrin clot dissolution) and Spraid (Mupirocin/Metronidazole broad-spectrum antibiotic spray for wounds, burns, and surgical sites).
• Nutrition & Supplement Products Standalone nutritional products including Black Soldier Protein Powder (hypoallergenic, USFDA/EU-approved insect protein from Black Soldier Fly larvae), Calowries (enzyme-based metabolism/fat-to-energy supplement), and Obex (weight management with fat-burner and lean-muscle support).
• Veterinary Specialty Diets Prescription-grade specialty diets including Gastrointestinal diets (Cat & Dog, dry and wet), Urinary S/O diets (urolithiasis and FLUTD, Cat & Dog), Renal Support diets (CKD management, Cat & Dog), Hypoallergenic Dog diet, Onco Support Dog diet (cancer-related symptoms), Weight Reduction Dog diet, Hepatic Support Dog diet, and Recovery Liquid diet (post-operative and recuperation).
• EasyPill Administration Aids EasyPill Cat & Dog (treat-pocket pill givers), EasyPill Gingiva (for cat gingiva upsets), and EasyPill L-Lysine (for cats) - compliance-aid products that facilitate medication administration.
• Other Specialty Therapeutics Other therapeutics including Finapet (Finasteride for benign prostatic hyperplasia in dogs) and Atovquin (Atovaquone + Azithromycin for Babesiosis, Cytauxzoonosis, and Pneumocystosis in dogs and cats).
• Bark Out Loud (D2C Premium Pet Care Sub-brand) Bark Out Loud is the direct-to-consumer premium pet care sub-brand of Vivaldis, offering science-backed nutrition products across food, treats, skincare, and supplements for dogs and cats. Operates as a 100% digital brand with influencer and community-led storytelling campaigns, AI-powered content/audience segmentation, and a focus on Tier-2 and Tier-3 Indian cities alongside metros.

Quantifiable outcome

• Product reach across India and over 30 countries

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• CatalysiscoreStrategic or Co-development PartnerGlobal partnership with Catalysis to bring advanced formulations to Indian pets. Catalysis is a globally renowned company providing innovative healthcare solutions.
• BioibericacoreStrategic or Co-development PartnerPartnership with Bioiberica, a globally renowned company, to bring advanced veterinary formulations to Indian pets.
• SupertailsminorGTM or Marketing PartnerBark Out Loud partnered with Supertails for the Paw Pageant 2025 event, India's biggest pet pageant, in association with Solitario.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Intas Animal Health: Animal health division of Intas Pharmaceuticals, one of India's largest veterinary pharma players with a broad therapeutic and nutraceutical portfolio sold to veterinarians. Closely comparable as an Indian-headquartered specialty animal health company selling through the vet channel.
• Hester Biosciences: India-listed animal health company specializing in vaccines and therapeutics for poultry and companion animals. Comparable as a homegrown Indian animal health company building a science-backed therapeutics franchise.
• Indian Immunologicals: Leading Indian animal and human biologicals manufacturer (subsidiary of NDDB), with growing presence in companion animal health and nutraceuticals. Comparable as an Indian-headquartered animal health company scaling specialty therapeutics.
• Virbac: France-based global specialty veterinary pharmaceutical company with deep presence in dermatology, cardiology, oncology, and nutrition for companion animals. Highly comparable product mix and prescriber-driven GTM.
• Dechra Pharmaceuticals: UK-based specialty veterinary pharmaceuticals and diets company (now under EQT) focused on companion animal endocrinology, dermatology, and critical care. Comparable as a specialty vet pharma plus therapeutic diet model.
• Vetoquinol: France-based specialty animal health company with strong companion animal franchise in pain, dermatology, and cardiology. Comparable therapeutic categories and vet-channel distribution model.
• Supertails: India's largest D2C pet care platform selling food, treats, supplements, and vet-care products online. Comparable as a direct competitor to Bark Out Loud in the Indian premium D2C pet parent segment.
• Heads Up For Tails (HUFT): India's leading premium pet retail and care brand with omnichannel presence across food, grooming, accessories, and vet services. Comparable as a premium-positioned Indian pet care brand competing for the same pet-parent wallet.

Broad incumbents

• Boehringer Ingelheim Animal Health: Global #2 animal health company with broad portfolio across vaccines, parasiticides, and therapeutics, including significant India operations. Comparable as a multi-category animal health competitor with deeper R&D and field force.
• Zoetis: World's largest pure-play animal health company with extensive companion animal portfolio (dermatology, oncology, parasiticides, diagnostics) and growing India presence. Comparable as the leading specialty incumbent Vivaldis must compete against.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/vivaldisanimalhealth
• LinkedInlinkedin.com/company/vivaldisanimalhealth
• Instagraminstagram.com/barkoutloud.official

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivaldis